- Home
- PCVX vs IDA Comparison
PCVX vs IDA Comparison
Compare PCVX & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCVX | IDA |
|---|---|---|
| Founded | 2013 | 1915 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.9B |
| IPO Year | 2020 | 1998 |
Fundamental Metrics
Financial Performance| Metric | PCVX | IDA |
|---|---|---|
| Price | $61.38 | $143.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | $98.33 | ★ $138.00 |
| AVG Volume (30 Days) | ★ 1.5M | 465.2K |
| Earning Date | 05-27-2026 | 05-22-2026 |
| Dividend Yield | N/A | ★ 2.45% |
| EPS Growth | N/A | ★ 7.27 |
| EPS | N/A | ★ 5.90 |
| Revenue | N/A | ★ $1,746,972,000.00 |
| Revenue This Year | N/A | $17.71 |
| Revenue Next Year | N/A | $8.67 |
| P/E Ratio | ★ N/A | $24.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.09 | $109.30 |
| 52 Week High | $76.61 | $145.94 |
Technical Indicators
Market Signals| Indicator | PCVX | IDA |
|---|---|---|
| Relative Strength Index (RSI) | 65.05 | 65.70 |
| Support Level | $42.30 | $124.57 |
| Resistance Level | N/A | $145.94 |
| Average True Range (ATR) | 3.27 | 3.09 |
| MACD | 0.36 | 0.20 |
| Stochastic Oscillator | 72.47 | 81.47 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About IDA IDACORP Inc.
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.